Table II.

Proportion of days without heartburn and mean severity of heartburn during the 4-week treatment period (full analysis set).

Measure	Median*	Q1, Q3*	P†
Proportion of days without heartburn
Placebo, n = 278	7.40	0.00, 39.30
Vonoprazan 10 mg, n = 278	10.30	0.00, 55.60	0.2310
Vonoprazan 20 mg, n = 271	12.00	0.00, 57.10	0.0504
Mean severity of heartburn
Placebo, n = 278	1.070	0.520, 1.950
Vonoprazan 10 mg, n = 278	0.990	0.360, 1.730	0.0440
Vonoprazan 20 mg, n = 271	0.960	0.320, 1.700	0.0139

Q1 = quartile 1; Q3 = quartile 3.

^⁎Values are presented as %.

^†Wilcoxon rank-sum test calculated on the median.